Dawn E Quelle has obtained her PhD in Biochemistry and Molecular Biology from the Pennsylvania State University. In her Post-doctoral work with Dr. Charles Sherr at St Jude Children’s Research Hospital, she studied cell cycle control and discovered the ARF tumor suppressor. She is an Associate Professor of Pharmacology at the University of Iowa and Leader of the Cancer Genes and Pathways Program in the Holden Comprehensive Cancer Center. Her research explores mechanisms of tumor suppression with a focus on the molecular and in vivo functions of ARFRABL6As binding partners, such as RABL6A, in cancer. Dawn E Quelle has obtained her PhD in Biochemistry and Molecular Biology from the Pennsylvania State University. In her Post-doctoral work with Dr. Charles Sherr at St Jude Children’s Research Hospital, she studied cell cycle control and discovered the ARF tumor suppressor. She is an Associate Professor of Pharmacology at the University of Iowa and Leader of the Cancer Genes and Pathways Program in the Holden Comprehensive Cancer Center. Her research explores mechanisms of tumor suppression with a focus on the molecular and in vivo functions of ARFRABL6As binding partners, such as RABL6A, in cancer.

Gastroenterology